General Information
Revision date
2015-04-21
Product name
PROCRIT
Substance name
EPREX / PROCRIT
CAS No.
113427-24-0
1.2.1 Relevant identified uses
Finished Pharmaceutical Product Large Molecule Pharmaceutical intended for medical use Pharmacotherapeutic group: Antianemic preparations This SDS is only intended for occupational use and not for
supplier name
Janssen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
Janssen Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJanssen@its.jnj.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361
Hazard statements
Code
Statements
H361
Suspected of damaging fertility or the unborn child
Section 2
2.1 Classification of the substance or mixture
Reproductive toxicity : Category 2
2.2 Label elements
Medicinal products in the finished state, intended for the final user, are not subject to GHS label- ing.
Signal word
Warning
Hazard statements
H361 Suspected of damaging fertility or the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
Avoid direct contact and significant aerosol/dust exposure which has the remote possibilities of eliciting an allergic respons. May cause sensitization of susceptible persons. Refer to the pharmacotherapeutic group (section 1.2) and the patient packaging insert to evaluate the possible workplace hazards when this Finished Pharmaceutical Product is accidently leaking, broken or crushed.
Ingredient(s) with unknown acute toxicity
58.96 %
